Despite numerous advances in our understanding of pancreatic ductal adenocarcinoma (PDA) genetics and biology, this disease is expected to become the second leading cause of cancer-related U.S. deaths within the next few years. Incomplete understanding of how it arises precludes development of early detection and interception strategies to improve therapeutic outcomes. Acinar to ductal metaplasia involving genesis of tuft cells is one early step in PDA formation, but their functional significance has remained obscure due to their rarity and a lack of methods and relevant animal models for their molecular and functional analysis. Here, we show that deletion of tuft cell master regulator Pou2f3 eliminates pancreatic tuft cells and increases fibrosis, alters immune cell activation, and accelerates disease progression. We demonstrate that tuft cell expression of the prostaglandin D 2 synthase Hpgds restrains pancreatic disease progression in early stages by inhibiting stromal activation. Analyses of human data sets are consistent with mouse studies. We propose that tuft cells and, by inference, the associated metaplastic lesions, play a protective role early in pancreatic tumorigenesis.
specifically eliminate tuft cells through genetic ablation of the tuft cell master regulator Pou2f3 (11) . We show here that pancreas-specific ablation of Pou2f3 prevents pancreatic tuft cell formation. Surprisingly, and in contrast to expectations from prior work, tuft cell ablation accelerates tumorigenesis. This identifies a protective role for tuft cells during tumor progression. We investigated the mechanisms underlying tuft cell function using small cell number RNA-sequencing, ultrastructural analyses, and metabolic profiling.
These studies produce a consistent picture involving tuft cell secretion of suppressive eicosanoids, such as prostaglandin D 2 (PGD 2 ), as an important mechanism of action for promoting pancreas homeostasis and restraining disease progression.
Results:
Tuft cell ablation accelerates tumorigenesis. Transcription factor Pou2f3 (also known as Skn-1a or Oct11) is the master regulator of tuft cell formation in several organs and its expression has recently been identified in pancreatic tumorigenesis (11, 24, 25) . We therefore used pancreas-specific Pou2f3 deletion as a genetic strategy to investigate tuft cell contribution to the formation of pancreatic intraepithelial neoplasia (PanIN) and tumor progression. The specificity of this strategy is supported by the fact that 99% of tuft cells in the LSL-Kras G12D ;Ptf1a Cre/+ (KC) mouse model of pancreatic tumorigenesis, identified by co-expression of tuft cell markers Cox1 and acetylated α-tubulin, express Pou2f3 (790/800 cells, 8 mice) ( Figure 1A) . Conversely, 93% of Pou2f3+ cells are definitively tuft cells (744/800 cells, 8 mice).
Previous studies of tuft cell function used full-body Pou2f3 knockout mouse models, which could generate phenotypes due to tuft cell-specific and/or collateral effects (11) . To increase specificity and eliminate influences from Pou2f3 ablation outside the pancreas, we generated a floxed Pou2f3 mouse model enabling selective deletion in the pancreas ( Figure 1B) . Importantly, Pou2f3 is not expressed in the normal murine pancreas ( Figure S1A ). Consequently, pancreata from Pou2f3 fl/fl ;Ptf1a Cre/+ (PouC) and full body Pou2f3-/-mice were normal in size and contained intact exocrine and endocrine compartments with no overt pathology (Figure S1B-C). Pou2f3 fl/fl mice were then bred into the KC model to generate KPouC mice. Age and sex matched KC and KPouC mice were sacrificed at 6 or 12 months and examined histologically. Pancreas-specific Pou2f3 deletion was confirmed by immunohistochemistry (IHC) ( Figure   1C -D). We then confirmed tuft cell deletion using IHC for multiple markers (Cox1, Trpm5, and Vav1; Figure 1C -D, Figure S2A ) as accepted tuft cell markers include inflammatory and neuronal proteins that are readily found in the stroma. Notably, Dclk1 was still expressed in KPouC pancreata, though at lower levels, demonstrating that its expression is not tuft cell-specific in the diseased pancreas ( Figure S2A ).
Consistent with the pancreas specificity of this knockout model, we readily detected tuft cells and associated expression of Pou2f3, Dclk1, Cox1, Trpm5, and Vav1 in the intestines of KPouC mice ( Figure   S2B ). Further, the lack of tuft cells in the pancreata of KPouC mice demonstrates that these cells do not migrate into the tissue during disease progression, but rather arise locally from the pancreas epithelium.
Although tuft cells are rare in the pancreata of 6-month-old KC mice, their absence in the KPouC pancreas correlated with accelerated tumorigenesis (Figure 1E -F). Pancreatic ductal adenocarcinoma (PDA) is thought to originate from metaplasia that has progressed through several steps of neoplasia (PanIN1a, PanIN1b, PanIN2, PanIN3) characterized by increasing nuclear atypia and loss of cellular polarity.
Pathologist assessment of pancreata from 6-month-old mice by hematoxylin & eosin staining (H&E) from each cohort (n = 8 for each group) revealed significantly more PanIN1b (39% of lesions vs. 19%) and more PanIN2 (10% of lesions vs. 1.2%) in KPouC mice as compared to control ( Figure 1E ). By 12 months, 100% of KPouC mice (n = 3) had frank adenocarcinoma (PDA) whereas only a single cancerous lesion could be identified in one of the KC mice (n = 3) ( Figure 1E-F) .
Given the known expression of inflammatory regulators in tuft cells, we next investigated the impact of tuft cell loss on disease progression in the context of injury. To answer this question, 6-week-old KC and KPouC mice were given a short course of caerulein, to induce acinar cell injury, and were then allowed to recover for two weeks (Figure 2A ). Pathologist scored H&E analysis revealed a trend towards higher grade PanIN in KPouC as compared to KC pancreata ( Figure 2B -C). Immunohistochemical evaluation revealed significantly less normal tissue (amylase, 21% vs. 69%) and greater myofibroblast activation (αSMA, 41% vs. 27%) and extracellular matrix deposition (ECM, i.e. hyaluronan, collagen) in KPouC mice ( Figure 2B , D, S3A-B). We identified significantly more apoptotic cells (CC3) and fewer proliferating cells (Ki67) as compared to KC pancreata ( Figure S3A-B ). There was a trend towards higher aberrant duct formation (Ck19) and immune cell infiltration (CD45) in KPouC mice, though it did not reach significance ( Figure S3A-B ).
These observations indicate that while tuft cells are rare, they play an important role in pancreatic disease progression by moderating early responses to tissue injury. The data further identify an unexpected role for tuft cells in inhibiting pancreatic tumorigenesis. To determine the mechanism of tuft cell tumor suppression, we evaluated KC tuft cells transcriptomically and ultrastructurally to identify possible mechanisms of action.
Transcriptomic analysis of tuft cells identifies lipid synthesis and metabolism pathways.
We used RNA-sequencing to gain insight into potential mechanisms by which pancreatic tuft cells impact tumorigenesis. As the tuft cell population is rare, we used FACS for Siglec f to isolate enough cells to perform low cell number RNA-seq. While Siglec f labels Cd45+ eosinophils, it is also expressed in intestinal tuft cells (100% + , 158/158 cells, 3 mice) (9, 11) and in pancreatic tuft cells in KC mice (99% + , 300/301 cells, 3 mice), but is not expressed in KPouC mice ( Figure 3A , S2A). Using flow cytometry, we identified significantly more Siglec f+;EpCAM+ cells in 8-10 month old KC mice (~1.8% of the epithelium, range 1.0%-4.6%, n = 5) than in normal pancreas (0.001%, n = 5), consistent with histological studies (Figure. S4A) (5) .
We isolated 100 Siglec f+;EpCAM+;Cd45-neg tuft cells and an equivalent number of Siglec fneg;EpCAM+;Cd45-neg non-tuft epithelial cells by FACS. We then isolated bulk RNA, prepared cDNA, and amplified it using the SmartSeq2 methodology to enable deep sequencing and comprehensive characterization of these small populations of cells (26) . RNA-seq identified 900 genes differentially expressed between Siglec f+; EpCAM+;Cd45-neg and Siglec f-neg; EpCAM+;Cd45-neg populations (p<0.05 and average fold change>4) ( Figure 3B ). Tuft cell enrichment was confirmed in the Siglec f+ population by expression of markers such as Pou2f3, Ptgs1 (Cox1), Trpm5, and Vav1, and low to no expression of acinar cell markers, such as Ptf1a, or islet cell markers, such as Chga ( Figure 3C , S4B-C, File S1) (5, 11, 27 ). Furthermore, highly expressed genes in the Siglec f-neg population were enriched for gene sets associated with digestion, consistent with acinar and islet cell function ( Figure S4D ).
We used this small cell number sequencing approach to conduct RNA-seq on normal intestinal tuft cells to assess their similarity to pancreatic tuft cells. We found that both intestinal and pancreatic tuft cell signatures significantly overlap with single cell intestinal tuft cell sequencing data (Haber et al.,) , validating our approach (Figure. S5) (28) . To further validate the use of Siglec f to isolate tuft cells from PanIN, we sorted 116 Siglec f+; EpCAM+;Cd45-neg cells and conducted single cell sequencing by Smartseq2. We found significant enrichment of tuft cell markers identified by our bulk RNA-seq analysis in 88% (102/116) of these cells (FDR<0.05, File S1), confirming that Siglec f labels tuft cells in the pancreas ( Figure S6 ).
Consistent with gene expression patterns identified in tuft cells from other systems, we identified expression of taste-signaling components (Trpm5, Gnat3, Gng13, Itpr3) and synaptic signaling markers (Stx1a, Stx7, Snap23, Snap29, Vamp2, Nrgn, Gabra1, Gabbr1, Chat) in KC tuft cells (File S1) (9, 29, 30) . Importantly, and in contrast with data obtained from intestinal tuft cells, Il25 and Sucnr1 were not measurably expressed ( Figure S7A ,D, File S1). Due to the established functional role for these genes in intestinal tuft cells, we confirmed their absence by RT-qPCR ( Figure S7B ,E). Further, we crossed IL25reporter mice (IL25 F25/+ ) into the KC model and could not identify IL-25 expression in pancreatic tuft cells ( Fig S7C) . Sucnr1 absence was confirmed with RNA in situ hybridization ( Figure S7F ). These data imply organ and/or context-specific tuft cell gene expression.
Network analysis of genes differentially expressed in KC tuft cells as compared to non-tuft epithelial cells highlighted a role in inflammation and identified pathways associated with lipid synthesis and metabolism, including eicosanoid biosynthesis and metabolism ( Figure 3D ). Eicosanoids are inflammatory lipid mediators with known roles in tumor progression. These data suggest that eicosanoid synthase Cox1 is not merely a tuft cell marker, but may also play a functional role.
Lipid droplets serve as sites of eicosanoid synthesis in KC tuft cells. Tuft cells are known for their striking morphology. Therefore, to ascertain any structure-function relationships in pancreatic tuft cells, we conducted detailed ultrastructural analyses using scanning electron microscopy (SEM) and serial block face electron microscopy (SBFEM). SEM analysis of pancreata from year-old KC mice captured the topography of PanIN including the long, blunt microvilli characteristic of tuft cells ( Figure 4A ). Tuft cells (apical surface area = 27.84 + 7.55 µm 2 , 10 cells) were identified by microvilli (390 + 143 per cell, 10 cells) width (215.9 + 46.36 nm, 10 cells, 120 microvilli) and length (567.48 + 144.18 nm, 10 cells, 100 microvilli) (n = 2 mice). We also noted the possible budding of vesicles from tuft cell microvilli, suggesting an active secretory role for tuft cells in the PanIN stage of PDA progression ( Figure 4A , S8A-B) (31) .
Identification of tuft cells by apical microvilli captured in a single plane obscures any information that may
be gathered about peri-nuclear and basal structures. Recently, Hoover et al., used a combination of SBFEM and SEM imaging of serial ultra-thin sections to describe ultrastructural features of intestinal tuft in 3D (32) . Therefore, to more completely evaluate pancreatic tuft cell ultrastructure, we performed SBFEM on PanIN from 6 and 12 month old KC mice. SBFEM uses an ultramicrotome mounted inside of a SEM to iteratively remove ultra-thin sections (<100 nm) of a resin embedded sample (or block) and images the newly revealed blockface with each slice. Images are produced by raster scanning the SEM beam across the sample surface and collecting the backscattered electrons that have interacted with the heavy-metal stained resin-embedded sample. We captured over 500 sections (100 nm thick) through a PanIN to reveal a nearly complete single tuft cell, capturing both the apical microvilli ( Figure 4B ) and the basal cytoplasmic constituents ( Figure 4C ) of the same cell. Segmentation and 3D reconstruction of some organelles from the processed image stack revealed the novel observation of over 180 perinuclear and cytoplasmic lipid droplets ( Figure 4C -E, S8C-D, Movie S1). Lipid droplets are compact organelles lined by a phospholipid monolayer, which appear as dark smooth roughly spherical organelles when imaged by EM.
Of 8 PanIN stacks acquired (~500 80-100 nm slices per PanIN), ~50% had tuft cells. In total, 9 tuft cells were analyzed and all had perinuclear and cytoplasmic lipid droplets (n = 3 mice), consistent with a functional role for lipid synthesis and metabolism in KC tuft cells (movie S2). We confirmed these EM observations by conducting co-immunofluorescence for tuft cell markers (Cox1, acetylated α-tubulin, and Dclk1) and the lipid marker Bodipy ( Figure 4F , S9), resulting in detection of lipid droplets in 63% of KC tuft cells (188/300 cells, 3 mice). As lipid droplets may be obscured by the 2D nature of this analysis or may be below the visual detection limit, it is possible that they were also present in the other 37% of tuft cells.
Lipid droplets have traditionally been thought of as innocuous lipid storage organelles, but recent data emphasize their role as dynamic players in lipid metabolism and immune regulation (33) . In fact, they have been reported to serve as inducible sites of eicosanoid synthesis in inflammatory cell populations, such as eosinophils, macrophages, and mast cells (34, 35) . In these populations, arachidonic acid is released from the lipid droplet phospholipid monolayer by cytosolic phospholipase A2 (cPLA2) and is then converted by Cox (cyclooxygenase) or Lox (lipoxygenase) enzymes to eicosanoids (33) . Co-localization of Cox1 and Bodipy suggests that pancreatic tuft cell lipid droplets serve as sites of eicosanoid synthesis ( Figure 4F ). Interestingly, Cox1 localizes to the nuclear membrane in tuft cells and a number of lipid droplets were found to associate closely with the nucleus (Movie S2). Although mechanisms of tuft cell eicosanoid secretion have yet to be elucidated, the basal localization of lipid droplets and their contact with the dense tubulin network within tuft cells suggest that secretion may occur basally and/or apically ( Figure S9 ).
Eicosanoid and eicosanoid synthase expression in pancreatic neoplasia. Our RNA-seq analysis of KC tuft cells demonstrates significant enrichment of eicosanoid synthases, including lipoxin, leukotriene, and prostaglandin synthases as well as the entire pathway of proteins necessary to generate leukotriene LTC 4 ( Figure S10A -C). We determined which eicosanoids are present in pancreatic neoplasia by analyzing a comprehensive panel of 157 eicosanoids in whole tissue (pancreata) from either wild-type or 8-10 month old KC, PanIN-bearing mice by mass spectrometry. Prostaglandin D 2 (PGD 2 ) was present at extraordinarily high levels (369 +/-102 pmol/mg, n = 5), while LTC 4 and downstream products were absent ( Figure 5A , File S2). We and others have documented expression of hematopoietic prostaglandin D 2 synthase (Hpgds) in pancreatic tuft cells, which was confirmed here by RNA-seq ( Figure S10B ) (4, 5, 9) .
Correspondingly, we found Hpgds expression to be absent from the epithelium of KPouC mice by IHC, suggesting that epithelial Hpgds is tuft cell-specific ( Figure S2A ). Importantly, mass spectrometry on pancreata from 6 month old KPouC mice and age-matched KC mice from the same colony revealed a 72% decrease in PGD 2 levels (695 +/-296 vs. 195 +/-164 pmol/mg) between the two genotypes ( Figure 5B ), suggesting that a significant amount of PGD 2 derives from tuft cell-specific synthesis and secretion. It is noteworthy that the different genetically engineered mouse models (GEMMs) used in these experiments were raised in different backgrounds (methods) and were kept in different facilities and, thus, underwent tumorigenesis at different rates, requiring that controls for each experiment be taken from the same mouse colony. PGD 2 has an extremely short half-life and has been shown to act locally (36) . This begs the question of the relevance of epithelial, tuft cell-derived PGD 2 to disease progression. We addressed this question by breeding a floxed Hpgds fl/fl allele into the KC model of pancreatic tumorigenesis to generate KHC mice ( Figure 5C ). This model selectively loses pancreatic epithelial Hpgds while maintaining stromal expression. Pancreata from Hpgds fl/fl ;Ptf1a Cre/+ (HC) mice contain intact exocrine and endocrine compartments with no overt pathologies ( Figure S11A ). Six-week-old KHC (n=8) and control KC mice (n=6) from the same colony were given a short course of caerulein and were sacrificed two weeks later as previously described (Figure 2A ). KHC mice treated with caerulein still form tuft cells, as identified by immunohistochemistry for markers Pou2f3, and Dclk1 ( Figure 5D ). Hpgds deletion was confirmed in KHC mice by IHC ( Figure 5D ), in situ hybridization ( Figure S11B ), and RT-qPCR of isolated epithelial cells collected by FACS ( Figure S11C ). To determine if deletion of epithelial-specific Hpgds is sufficient to decrease PGD 2 levels, we conducted mass spectrometry on pancreata from caerulein treated KHC mice or treatment-matched KC mice from the same colony. We found a 79% decrease in PGD 2 levels (543 +/-341 vs. 114 +/-99 pmol/mg) between the two genotypes ( Figure 5E ). Consistent with the phenotype determined in KPouC mice, pathologist-scored H&E analysis revealed significantly more PanIN1b (32% of lesions vs. 9.8%) and more PanIN2 (10% of lesions vs. 3.3%) in KHC mice as compared to control ( Figure   5D , F). Collectively, these data demonstrate that tuft cell suppression of pancreatic tumorigenesis occurs, in part, through secretion of Hpgds-derived PGD 2 .
PGD 2 restrains disease progression by promoting environmental homeostasis.
Elevated expression of stromal αSMA in KPouC mice, as compared to KC mice, suggests that loss of PGD 2 may contribute to pancreatic stellate cell (PSC) activation and desmoplasia. We addressed this possibility by treating primary, activated murine PSCs with prostaglandins in vitro. Treatment with PGE 2 , as a proinflammatory control, increased expression of activation markers such as Acta2 (αSMA) and growth factors such as Ctgf as determined by RNA-seq and confirmed by RT-qPCR (Figure S12A-C). By contrast, PGD 2 treatment significantly decreased Acta2 expression, as determined by RNA-seq and confirmed by RT-qPCR ( Figure 5G , S12D-F, File S3). Correspondingly, we also saw a significant decrease in expression of ECM proteins Col1a1 and Col5a1, Ctgf, and the hyaluronan synthase Has2 (Figure 5G , S12E-F, File S3). Prostaglandins are known inflammatory mediators in injury formation, resolution, and tumorigenesis (38) . PPARγ expression has been described in a number of immune cell populations and activation is known to suppress inflammation (39) . As a model for assessing whether PGD 2 itself is able to suppress inflammatory cell activation, we treated naïve or polarized bone marrow-derived macrophages (BMMs) in vitro with PGD 2. RNA-seq analysis of naïve BMMs treated with PGD 2 reveals induction of anti-oxidant genes and, as previously reported, a shift towards an anti-inflammatory macrophage phenotype (Figure S13A-B) (40) . Lipopolysaccharide (LPS) induces a strong pro-inflammatory response in macrophages ( Figure   S13C ), and subsequent treatment with PGD 2 resulted in 322 genes being differentially expressed between control and LPS/PGD 2 -treated BMM ( Figure S13D , File S4). PGD 2 treatment resulted in suppression of proinflammatory interferon signaling pathways and a significant decrease in cytokine expression ( Figure 5H , S13E-F).
We next turned to a genetic approach to determine whether PGD 2 is sufficient to inhibit pancreatic tumorigenesis. We bred HPGDS transgenic mice, which express 375 fold more human HPGDS over endogenous mouse Hpgds, into the KC model (KCHTg mice) (41) . Even with such a large increase in HPGDS expression, these mice are born with a normal pancreas with no overt pathologies ( Figure S11D ).
Correspondingly, we found a significant increase in PGD 2 levels in the pancreata of 6-month-old transgenic mice as compared to wild-type mice from the same colony ( Figure 5I ). Interestingly, when we examined PGD 2 expression in 6-month-old KC and KCHTg mice, we did not identify significant differences in PGD 2 levels, suggesting that mutant Kras-driven alterations to the pancreas are sufficient to drive high levels of PGD 2 by 6 months of age ( Figure S11E ). However, when we examined disease progression, we found more advanced disease in 6-month-old KC mice (2/8 mice had frank adenocarcinoma) as compared to KCTg mice (0/7 mice had frank adenocarcinoma), suggesting that high PGD 2 expression is sufficient to attenuate pancreatic tumorigenesis in early stages ( Figure 5J -K).
Pancreatic tuft cells in human disease. Tuft cells are also associated with human pancreatitis and
PanIN, suggesting a conserved role across species (5) . To infer the function of tuft cells in human pancreas disease, we evaluated tuft cell marker expression in RNA-seq data collected from human samples. To do this, we laser-capture dissected and sequenced the epithelium from 45 patients with precursor lesions (26 PanIN and 19 IPMN) and 197 patients with PDA (as described in (42) . We then generated and overlaid a humanized version of our KC tuft cell signature on these data (KC Tuft single sample gene set enrichment analysis, ssGSEA) and found significantly higher expression in precursor lesions than cancer, consistent with tuft cell formation early in disease progression followed by loss later on (p<0.01, Figure 6A ) (5) . Tuft cell markers, such as AVIL, TRPM5, GNG13 and RGS13 were enriched in precursor lesions ( Figure 6A ) (9) . Interestingly, and consistent with results in the KC mouse model, IL25
was not detected. HPGDS expression, though, is significantly higher in precursor lesions than PDA, consistent with tuft cell expression ( Figure 6B ). To evaluate Hpgds protein expression, we conducted multiplex immunofluorescence for Hpgds and tuft cell marker phospho-EGFR on metaplasia and PanINbearing human pancreatitis samples (5) . Though rare, we found that 100% of pancreatitis tuft cells (30/30; n=3 patients) express Hpgds at the protein level ( Figure 6C ), consistent with studies in normal human pancreas (19) . We then conducted eicosanoid profiling on PDA (n=6) and nearby normal pancreas (n=3) ( Figure S14A , File S5), but were unable to include human PanIN due to lack of available fresh tissue. Consistent with gene expression, PGD 2 levels were very low in both PDA and nearby normal tissue ( Figure S14B ). Collectively, these data suggest that Kras G12D -induced tuft cells in both mouse and human disease utilize local, paracrine PGD 2 signaling to curb activation of the tumor microenvironment and suppress disease progression ( Figure 7 ).
Discussion:
Despite much conjecture over a pro-tumorigenic role for tuft cells in pancreatic tumorigenesis, we have found that eliminating tuft cells accelerates tumor formation, identifying a protective role for this cell type.
Tuft cells, rather than seeding cancer, instill homeostasis in part through generation and secretion of lipid eicosanoid mediators. Consistent with this, our ultrastructural analyses identified the previously undescribed presence of lipid droplets in PanIN tuft cells, which may function in eicosanoid synthesis.
Eicosanoid synthase expression, namely Cox1 and Hpgds, has been shown in tuft cells from a number of gastrointestinal organs and is often used to detect these cells (4, 9) . However, a functional role for tuft cell-derived prostaglandins has not previously been demonstrated. We show here that ablation of tuft cell PGD 2 synthase Hpgds enhances pancreatic injury and disease progression. HPGDS and PGD 2 overexpression is sufficient to inhibit pancreatic tumorigenesis. The global suppressive effects of PGD 2 include inhibition of mPSC and BMM activation ( Figure 7 ).
An anti-inflammatory role for PGD 2 has previously been demonstrated in the context of injury and tumorigenesis in several organs (43) . Correspondingly, reduction of PGD 2 through Hpgds ablation has been shown to be pro-tumorigenic in lung and colon cancer models (41, 43) . Though we were unable to reliably detect either PGD 2 receptor, we identified expression of derivative PGJ 2 receptor PPARγ in both the epithelium and stroma. Within the epithelium, expression was largely restricted to tuft cells themselves suggesting an autocrine signaling loop. PPARγ has a known role in lipid droplet formation implying a role in eicosanoid synthesis with interesting implications for tuft cell regulation. Within the stroma, PPARγ activation is known to suppress mPSC activation and is a mechanism by which the inflammatory system regulates itself through suppression of Nf-κb (39, 44) . Further, PPARγ activation has been shown to inhibit tumor progression and metastases in mouse models of PDA (45) .
While PGD 2 synthesis and secretion is one attractive mechanism for tuft cell tumor suppression, these cells express additional immune modulators, including other eicosanoid synthases, which deserve further investigation (9) . For example, in addition to Cox1, we have found that PanIN tuft cells express leukotriene synthase Alox5. While PGD 2 is the most highly up-regulated eicosanoid in PanIN, Alox 5derived 5-HETE is also highly expressed ( Figure 5A ) and has been described to have both pro and antiinflammatory roles. These data also underscore the importance of elucidating the role of eicosanoids in PDA formation and progression.
Interestingly, RNA-seq of PanIN tuft cells also identified a number of anti-bacterial and viral infection associated genes that could act in a pro-inflammatory manner (File S1) (46) . These genes are also expressed in normal tuft cells from other organs, consistent with the predicted sentinel role for this cell type (9) . While it is possible that these mediators are constitutively and simultaneously expressed, we favor a model where tuft cells function as a component of innate immunity and release different effectors depending on disease context. Consistent with this idea, we have discovered and characterized tuft cell formation in mouse models of pancreatitis (submitted manuscript). Though both are derived from acinar cells, pancreatitis and PanIN tuft cells differ significantly in expression of important effectors. For example, though we could not detect IL-25 in PanIN tuft cells, expression was evident in those associated with pancreatitis. These data demonstrate that we are just scratching the surface on understanding tuft cell function and regulation in disease.
These data also reinforce the view that metaplastic lesions function in tissue healing and injury resolution, but provide a new mechanistic perspective. Our data indicate that metaplastic lesions facilitate healing, in part, by generating differentiated, functional secretory cells, which signal to the microenvironment to contain disease progression, promote healing, and preserve organ function. In the setting of neoplasia, where the tissue cannot heal, we see an accumulation of tuft cells whose net effect is to abate transformation. To our knowledge, this is the first example of an epithelial-derived tumor suppressive cell type. Tuft cell formation may be one reason that humans can live with PanIN lesions for decades without progression to carcinoma. We often hear of mechanisms by which cancer cells evade the immune system and promote their own survival, but here we describe a mechanism by which the epithelium protects itself from these life-threatening events. Elucidating these protective mechanisms will allow us to understand when they fail or how to co-opt them for therapeutic benefit.
Mice. Mice were housed in accordance with NIH guidelines in Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited facilities at the Salk Institute for Biological Studies. The Institutional Animal Care and Use Committee at the Salk Institute approved all animal studies (protocol 2011-0005). LSL-Kras G12D/+ ; Ptf1a Cre/+ (KC, mixed C57BL/6J background) mice have been previously described in detail (47) . KC mice conditionally express endogenous physiologic levels of activated Kras G12D targeted to progenitor cells of the developing pancreas. These animals spontaneously develop the full spectrum of precursor ductal lesions (pancreatic intraepithelial neoplasia, PanIN).
FLARE25 (Il25 F25/F25 , C57BL/6J background) mice were generously provided by the Locksley (University of California San Francisco, CA) and von Moltke laboratories (University of Washington, WA) (13) . Pou2f3 fl/fl (Pou) mice were generated using a classical gene targeting method with BA1 embryonic stem cells, a hybrid of C57BL/6J and 129SvEv strains, by homologous recombination, resulting in deletion of 1303 base pairs from the Pou2f3 gene. Chimeric mice were generated by inGenious Targeting Laboratories, were mated to flippase mice (in a C57BL/6J background), and then the obtained neo-deleted heterozygous mice were crossed with C57BL6J mice to remove the flippase allele. The resulting mice were pure heterozygotes (C57BL/6J, 87.5%; 129SvEv, 12.5%). Hpgds fl/fl (mixed C57Bl/6 strain background), and Hpgds-Tg mice (mixed FVB strain background) have been described previously (41, 48) . Information on primary antibodies is provided in Table S1 . Slides were then washed, incubated in streptavidin-conjugated secondaries (for rabbit or mouse antibodies, Abcam, for rat or goat antibodies, Vector, for HABP, ABC HRP kit, Vector) and developed with DAB substrate (Vector). For trichrome staining, slides were stained using a kit (IHC world) according to the manufacturer's instructions. Hematoxylin and eosin (H&E) staining was done to assess tissue morphology. All slides were scanned and imaged on an Olympus VS-120 Virtual Slide Scanning microscope. For quantification of histology, 10, 10x fields per scanned slide were scored in a blinded fashion using the ImageJ/FIJI plugin Immunohistochemistry (IHC) Image Analysis Toolbox (49) . A statistical color detection model was trained based on multiple regions of interest (ROIs) manually selected from desired color pixel regions from sample images for each stain using the IHC Toolbox plugin. Each image was color deconvolved using its corresponding trained model within the plugin and a new RGB image containing only the isolated color was automatically generated.
The hematoxylin counter stain was deconvolved in a similar manner. Using ImageJ/FIJI, the desired colorisolated image and the counter stain-isolated image were binarized and staining area of the two was measured by counting the number of pixels of foreground (50) . The percentage of signal was determined by dividing the stain area by the sum of the stain area and the counter stain.
Fluorescence microscopy. Tissues were fixed for 3-4 hours in 4% paraformaldehyde, washed 3x with PBS and floated overnight in 30% sucrose. Tissues were then incubated in a 1:1 mixture of 30% sucrose and Tissue-Tek optimal cutting temperature compound (OCT, VWR) for 30 min, embedded in OCT and frozen at -80°C. 7 µm tissue sections were cut, permeabilized with 0.1% Triton X-100 in 10 mM PBS, and blocked with 5% normal donkey serum and 1% BSA in 10 mM PBS for 1 hour at room temperature. Tissue sections were stained with primary antibodies in 10 mM PBS supplemented with 1% BSA and 0.1% Triton X-100 overnight (Table S1 ). Sections were then washed 3 x 15 min in PBS with 1% Triton X-100, incubated in Alexa Fluor secondary antibodies and/or phalloidin (Invitrogen), washed again for 3 x 5 min, rinsed with distilled water, and mounted with Prolong Gold containing Dapi (Invitrogen).
Immunofluorescence on paraffin-embedded tissues followed the immunohistochemistry protocol until the blocking step. Instead, tissues were blocked in the donkey serum block described above and then followed the protocol for fluorescence microscopy described here. Tissues were imaged on either a Zeiss 710 confocal microscope or a Zeiss 880 Airyscan Super-Resolution microscope.
Multiplex immunofluorescence. Co-expression of Hpgds and phospho-EGFR in human pancreatitis
(antibodies , Table S1 ) was determined using a Perkin Elmer Opal 4-color Manual IHC Kit (NEL810001KT) per the manufacturer's instructions. Okazaki, Japan) to make the resin more conductive under the electron beam (52) . Semi-thin sections (0.5-1.5 µm) were collected and examined with Toluidine blue staining using a light microscope until a region with a number of PanINs was identified. The block face was then trimmed to a roughly cubic face with a side-length of 300µm using glass and diamond trimming knives (Diatome) and an ultramicrotome (Leica) so that stained tissue was exposed on all sides, and a shallow notch was trimmed in a corner for orientation. The sample was then cut free from the block with a razor blade, and mounted flat on an aluminum 3View pin (Gatan) using toothpicks and conductive silver epoxy (EMS) before curing overnight in a 70°C oven. Pins were then sputtered (Leica) with about 15 nm of palladium, ultrathin sections were collected and the block face polished using a diamond knife, before finally loading pins into the 3View system (Gatan) mounted in a Zeiss Sigma VP scanning electron microscope. Over 500 sections, cut at a nominal thickness of 100 nm, were imaged with rasters of 20,000 x 20,000 pixels (1.2 kV, 1.5µs dwell time) with a pixel size of 16 nm pixels, creating a field of view measuring approximately 340µm x 340µm.
In situ hybridization. Sucnr1 expression was validated in situ using the RNAScope Multiplex Fluorescent
Image Processing. Raw stacks were rigidly aligned using the Linear Stack Alignment with SIFT plugin (https://imagej.net/Linear_Stack_Alignment_with_SIFT) in Fiji (NIH) and the region of interest was cropped into a substack. An affine alignment was performed using SIFT again, and a gaussian blur of 0.7 pixels was applied to reduce apparent shot noise to ease segmentation. The series was then loaded into Reconstruct software (53) and the basement membrane, along with the tuft cell plasma membrane, nucleus, microvilli, and lipid droplets were traced through the series by hand. The segmented data were then imported into Cell Blender (54, 55) , an extension of Blender software (2019), from which 3D meshes were generated and optimally smoothed using GAMer (https://arxiv.org/pdf/1901.11008.pdf). The 3-D models of the segmented organelles were rendered and analyzed in Blender using Neuromorph (https://github.com/NeuroMorph-EPFL/NeuroMorph).
All images (IHC, IF, EM) were digitally enhanced to edit the color, brightness and contrast levels using Zen (Carl Zeiss), ImageJ (Fiji), and/or Photoshop (Adobe) software.
Stellate cell isolation and culture. Mouse pancreatic stellate cells (mPSCs) were isolated from the pancreata of wild-type CD1 mice as previously described (56) . Pancreata from 2-3 mice were pooled prior to isolation. Briefly, pancreatic tissue was minced and digested with 0.02% Pronase (Roche), 0.05% Collagenase P (Roche), and 0.1% Dnase (Roche) in Gey's balanced salt solution (GBSS, Sigma) at 37°C for 20 min. Digested tissue was then filtered through a 100 µm cell strainer (Fisher). Washed cells were resuspended in 9.5 ml GBSS containing 0.3% BSA (Sigma) and 8 ml of 28.7% Histodenz solution (Sigma).
The cell suspension was layered beneath GBSS containing 0.3% BSA, and centrifuged at 1400 x g for 25 min at 4°C. Cells of interest were harvested from the interface of the Histodenz solution and the aqueous solution. Isolated mPSCs were washed with GBSS and re-suspended in DMEM (Fisher Scientific) supplemented with 20% FBS (Peak Serum), 100 mM Sodium Pyruvate (Life Technologies), 2 mM L-Glutamine (Life Technologies), 1x non-essential amino acids (Life Technologies) and antibiotics (penicillin 100 U/ml and streptomycin 100 mg/ml, Life Technologies). mPSCs were allowed to activate in culture and were then treated for 48 hrs with either prostaglandins (10 µM), control (methyl acetate, MeOAc), or Ppar agonists (Rosiglitazone, 100nm; GW7647, 1µM; GW501516, 100nM) in serum-free media before collection in Trizol (Thermofisher) for RT-qPCR or RNA-sequencing. A minimum of three biological replicates was analyzed per experiment.
Macrophage isolation, differentiation, and culture. Bone marrow-derived macrophages (BMM) were generated from bone marrow extracted from the femurs of male CD1 mice as previously described (57) . Intestinal tuft cells were isolated as previously described (11) . Briefly, the proximal 5 cm of the murine small intestine was dissected, flushed, cut longitudinally, and rinsed to remove luminal contents.
Segments were incubated in a 37°C shaker for 20 min in 5 ml PBS containing 2.5 mM EDTA, 0.75 mM dithiothreitol (DTT), and 10 µg/ml DNAse I. Tissues were shaken vigorously for 30s, large pieces of intestinal wall were removed, and cells were spun down at 4°C, 1200 rpm, for 5 min. Supernatant was removed and cells were re-suspended in 5 ml HBSS with 1.0 U/ml Dispase and 10µg/ml DNAse I, shaking for 10 min. Digested cells were passed through a 100 µm filter and incubated with ACK lysing buffer. Table S2 . Hpgds RT-qPCR data was normalized by the delta-delta-Ct method to housekeeping gene Gapdh.
Single cell suspensions were incubated on ice with mouse Fc receptor block (BD Biosciences

RNA-seq library generation, High-throughput sequencing, and analysis. Low input bulk RNA
sequencing (RNA-seq) on intestinal and pancreatic tuft cells was performed using the Smart-Seq2 protocol as previously described (26) . In brief, a minimum of three biological replicates, each with 100 tuft cells from an individual mouse, was sorted directly into 2 µl of Smart-Seq2 lysis buffer. Full-length cDNA was generated and size distribution representing RNA integrity was checked with Agilent TapeStation 4200 to ensure RNA quality. cDNA were then amplified with 18-22 PCR cycles, tagmentated with TDE1, and amplified again with 10 PCR cycles using a Nextera XT kit (Illumina FC-131-1096). The sequencing library purification was performed with AMPure XP beads (Beckman Coulter A63881), and 50 bp single-end sequencing was performed with Illumina HiSeq 2500. After quality check with FastQC, the fastq reads were mapped to the mm9 mouse genome using Hisat2 (58), followed by transcript assembly and quantification with Stringtie and Ballgown (59) . Between samples total gene expression distribution was checked with boxplot to ensure similar transcriptome quality. None expressed genes were defined as RPKM variance across samples < 1 and were removed, followed with log2 transformation and quantile normalization with the R package preprocessCore. Differential expression analysis between tuft and nontuft epithelial cells was performed with empirical Bayes shrinkage and moderated t-test using the Limma package and p values were converted into false discovery rates (FDR) using the Benjamini-Hochberg procedure (60) . Differential expression heat map plotting and hierarchical clustering (with Euclidean distance and complete linkage) were performed with heatmap.2 in R. Pathway analysis was performed with GSEA (http://software.broadinstitute.org/gsea/index.jsp) using a ranked differential expression score and the MSigDB geneset database (61). The differential expression score was calculated as: -log 10 (FDR) X log 2 (fold change), which factors in both statistical confidence and the effect size. Gene ontology network analyses of differentially expressed genes were performed with ClueGO plug-in of Cytoscape (62, 63) .
For sequencing of mPSCs and BMMs, RNA quality was assessed using the Agilent TapeStation 4200 and RNA-Seq libraries were prepared using the TruSeq stranded mRNA Sample Preparation Kit v2 according to Illumina protocols. Multiplexed libraries were validated using the Agilent TapeStation 4200, normalized and pooled for sequencing. High-throughput sequencing was performed on the HiSeq 2500 system (Illumina). Image analysis and base calling were done with Illumina CASAVA-1.8.2. For mPSCs, data analysis was performed as described above, except that an additional batch effect removal step was performed on the normalized RPKM value using the R package SVA (64) .
Smart-Seq2 single-cell analysis.
Reads were aligned to the mm10 mouse genome using STAR version 2.5.3a (65) . Mapping was carried out using default parameters, filtering non-canonical introns and allowing up to 10 mismatches per read and only keeping uniquely mapped reads. Raw transcript counts were obtained using HTSeq version 0.9.1 (66) . The union of all detected genes was compiled into a single expression table (156 cells and 28,002 genes). Cells with less than 500 unique genes and genes expressed in fewer than 3 cells were filtered using the Seurat R package (67) leaving 116 cells and 10,876 genes. Genes were log-normalized, z-scaled, and centered prior to dimensionality reduction and visualization. Before performing dimensionality reduction, a list of 3,105 most variable genes was generated using the FindVariableGenes function from the Seurat R package which calculates the average expression and dispersion for each gene, places these genes into bins, and then calculates z-score for dispersion within each bin. We then performed principal component analysis (PCA) over the list of variable genes and the first ten principal components were used for t-stochastic neighbor embedding (t-SNE).
Heatmaps were generated using heatmap.2 R package. The tuft cell signature genes (FDR<0.05, log2FC>1 from Supplemental File 1) were intersected with the genes expressed in the scRNA-seq Tuft cells and the resulting 99 up-regulated and 20 down-regulated genes were used to color the t-SNE plot.
To calculate significance of the tuft cell signature in each cell, the top 100 expressed genes were tested for significant overrepresentation of 109 genes upregulated in Tuft cells (FDR<0.05) using the hypergeometric distribution and setting the background to 10,876 expressed genes in the scRNA-seq Tuft cells. The -log10(FDR) was used to color the t-SNE plots indicating level of significance (102/116 cells at an FDR threshold of 0.05).
Comprehensive eicosanoid panel.
Eicosanoid profiling was conducted on flash-frozen pancreatic tissue from wild-type, caerulein-treated, or 8-10 month old KC mice. Tissues were homogenized in 1 ml of PBS containing 10% ethanol and 300 µl were extracted using strata-x polymeric reverse phase columns (88-S100-UBJ Phenomenex). Samples were taken up in 50 µl of 63% H 2 0, 37% ACN, 0.02% Acetic Acid, and 10 µl was injected into UPLC (ACQUITY UPLC System, Waters) and analyzed on a Sciex 6500 Qtrap mass spectrometer at the University of California, San Diego, Lipidomics Core as previously described (68) .
Samples were normalized to total protein content. PGD 2 levels in KC vs. KPouC, KC vs. KHC, KC vs.
KCHpgds-Tg, and wild-type vs. Hpgds-Tg mice were evaluated by performing direct metabolomics at UNMC as previously described (69) .
Analysis of tuft cell gene signatures in human PDA. Compartment-specific gene expression profiles
of human IPMN (n =19), PanIN (n = 26) and PDA (n = 197) were generated using laser capture microdissection with subsequent RNA sequencing as described previously (42, 70) . These samples have not been previously published (manuscript in preparation). Raw counts from RNA sequencing were then normalized to account for different library sizes, and the variance was stabilized by fitting the dispersion to a negative-binomial distribution as implemented in the DESeq2 R package (71) . Differential expression analysis was carried out using the limma R package between basal-like and classical PDA, basal-like PDA and precursor lesions and classical PDA and precursor lesions, respectively, and only those tuft cell genes achieving an FDR <= 0.05 at least once were retained. T statistics per gene from the three comparisons were integrated using their median and only those genes with an absolute integrated t statistic > 2 were kept for display in a heatmap using the pheatmap R package (http://CRAN.Rproject.org/package=pheatmap). Single sample GSEA (ssGSEA) of the KC tuft cell signature genes in human PDA was carried out using the VIPER framework (72) . Model for tuft cell suppression of pancreatic tumorigenesis. The scheme at the top represents Kras G12D -induced pancreatic tumorigenesis. In this scenario, acinar cells expressing Kras G12D undergo metaplasia to form aberrant, heterogeneous, ductal structures containing tuft cells. Among the potential secretory products of tuft cells, PGD 2 is released basally and/or apically and suppresses activation of associated stroma, including pancreatic stellate cells and immune cells. Metaplasia advances to pancreatic intraepithelial neoplasia (PanIN), but the process is slow. In the scheme at the bottom, acinar cells expressing Kras G12D , but depleted of Pou2f3, undergo metaplasia to form aberrant ductal structures lacking tuft cells. The lack of local, epithelial PGD 2 secretion impairs homeostasis, leading to prolonged activation of stromal populations and accelerated pancreatic tumorigenesis. 
